文献速递关节外科

使用INBONE II假体行全踝关节置换翻修术的临床与影像学结果

Clinical and Radiographic Outcomes of Revision Total Ankle Arthroplasty Using the INBONE II Prosthesis.
PubMed 文献 · J Bone Joint Surg Am · 2022-06-28

本研究回顾性分析了英国一家高手术量中心28例患者共29例使用INBONE II全踝系统行翻修性全踝关节置换术的病例,翻修主要原因为无菌性松动(83%)。平均随访40个月时假体生存率97%,感染率7%,再手术率7%,影像学对线参数及MOXFQ各领域和EQ-5D 3个领域评分均显著改善。作者认为翻修性全踝关节置换术是失败初次置换的满意选择。

要点

  • 翻修性全踝关节置换术主要适应证为初次置换后无菌性松动(83%)。
  • 平均随访40个月时假体生存率97%,感染率和再手术率均为7%。
  • 术后影像学对线参数显著改善,MOXFQ各领域及EQ-5D 3个领域评分显著改善。

核心结论

  • 使用INBONE II假体行翻修性全踝关节置换术与良好的短期生存率及术后2年评分改善相关。
  • 随访中记录了术后改善的对线得以维持。
  • 本研究结果支持翻修性全踝关节置换术是失败初次全踝关节置换术的满意选择这一观点。

研究设计与样本

  • 本研究为回顾性综述,纳入英国一家高手术量中心28例患者共29例使用INBONE II全踝系统(Wright Medical Technology/Stryker)行翻修性全踝关节置换术的病例。
  • 分析了人口学、影像学和患者报告结局测量数据。
  • 证据等级为治疗性IV级。

主要发现

  • 从初次全踝关节置换术到翻修的平均时间为87.5个月(范围16至223个月)。
  • 翻修的主要指征为初次全踝关节置换术后无菌性松动(83%)。
  • 76%的踝关节需要附加手术。
  • 在平均40个月(范围24至60个月)的随访中,感染率为7%,再手术率为7%,假体生存率为97%。
  • 术后影像学假体组件对线测量指标显著改善;本研究中下沉、松动和异位骨化发生率与其他报道相当,且未影响临床结局。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The literature on the outcome of revision total ankle arthroplasty (TAA) remains limited. In this study, we aimed to report the clinical and radiographic outcomes of revision TAA at a high-volume center in the United Kingdom. METHODS: This study was a retrospective review of 28 patients who underwent 29 revision TAAs using the INBONE II Total Ankle System (Wright Medical Technology/Stryker). Demographic, radiographic, and patient-reported outcome measure data were analyzed. RESULTS: The mean duration from primary TAA to revision was 87.5 months (range, 16 to 223 months). The main indication for the revision was aseptic loosening after the primary TAA (83%). Additional procedures were required in 76% of ankles. At a mean follow-up of 40 months (range, 24 to 60 months), the infection rate was 7%, the reoperation rate was 7%, and the implant survival rate was 97%. A significant postoperative improvement in the radiographic component alignment measures was observed. The subsidence, loosening, and heterotopic ossification rates in this study were comparable with those in other reports and did not influence the clinical outcome. A significant improvement was observed in the Manchester-Oxford Foot Questionnaire (MOXFQ) in all domains and the EuroQol-5 Dimensions (EQ-5D) in 3 domains at 24 months postoperatively. CONCLUSIONS: Revision TAA using the INBONE II prosthesis was associated with good short-term survival and improvement in postoperative scores at 2 years. Maintenance of the postoperatively improved alignment was documented at the follow-up. The results of this study support the notion that revision TAA is a satisfactory option for failed primary TAA. LEVEL OF EVIDENCE: Therapeutic Level IV . See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Jamjoom BA, Siddiqui BM, Salem H, et al. Clinical and Radiographic Outcomes of Revision Total Ankle Arthroplasty Using the INBONE II Prosthesis. J Bone Joint Surg Am. 2022. PMID: 35766416. doi:10.2106/JBJS.21.01240

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。